Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 376

1.

Immunotherapeutics in development for prostate cancer.

Harzstark AL, Small EJ.

Oncologist. 2009 Apr;14(4):391-8. doi: 10.1634/theoncologist.2008-0240. Epub 2009 Apr 2. Review.

PMID:
19342474
[PubMed - indexed for MEDLINE]
Free Article
2.

Advances in prostate cancer immunotherapies.

Basler M, Groettrup M.

Drugs Aging. 2007;24(3):197-221. Review.

PMID:
17362049
[PubMed - indexed for MEDLINE]
3.

Therapeutic vaccines for prostate cancer.

Cha E, Fong L.

Curr Opin Mol Ther. 2010 Feb;12(1):77-85. Review.

PMID:
20140819
[PubMed - indexed for MEDLINE]
4.

Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon.

[No authors listed]

Drugs R D. 2006;7(3):197-201. Review.

PMID:
16752945
[PubMed - indexed for MEDLINE]
5.

Prostate cancer immunotherapy.

McNeel DG.

Curr Opin Urol. 2007 May;17(3):175-81. Review.

PMID:
17414515
[PubMed - indexed for MEDLINE]
6.

Advances in specific immunotherapy for prostate cancer.

Kiessling A, Füssel S, Wehner R, Bachmann M, Wirth MP, Rieber EP, Schmitz M.

Eur Urol. 2008 Apr;53(4):694-708. Epub 2007 Nov 26. Review.

PMID:
18061335
[PubMed - indexed for MEDLINE]
7.

Progress in active specific immunotherapy of prostate cancer.

Tjoa BA, Murphy GP.

Semin Surg Oncol. 2000 Jan-Feb;18(1):80-7. Review.

PMID:
10617899
[PubMed - indexed for MEDLINE]
8.

Recent clinical development of dendritic cell-based immunotherapy for prostate cancer.

Rini B.

Expert Opin Biol Ther. 2004 Nov;4(11):1729-34. Review.

PMID:
15500401
[PubMed - indexed for MEDLINE]
9.

Immunotherapy for metastatic prostate cancer.

Drake CG.

Urol Oncol. 2008 Jul-Aug;26(4):438-44. doi: 10.1016/j.urolonc.2007.03.029. Epub 2007 Dec 21. Review.

PMID:
18593624
[PubMed - indexed for MEDLINE]
10.

Granulocyte-macrophage colony-stimulating factor-transduced allogeneic cancer cellular immunotherapy: the GVAX vaccine for prostate cancer.

Simons JW, Sacks N.

Urol Oncol. 2006 Sep-Oct;24(5):419-24. Review.

PMID:
16962494
[PubMed - indexed for MEDLINE]
11.

Development of dendritic-cell based prostate cancer vaccine.

Tjoa BA, Murphy GP.

Immunol Lett. 2000 Sep 15;74(1):87-93. Review.

PMID:
10996633
[PubMed - indexed for MEDLINE]
12.

Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.

Hwang C, Sanda MG.

Curr Opin Mol Ther. 1999 Aug;1(4):471-9. Review.

PMID:
11713762
[PubMed - indexed for MEDLINE]
13.

Dendritic cells: emerging roles in tumor immunotherapy.

Buchsel PC, DeMeyer ES.

Clin J Oncol Nurs. 2006 Oct;10(5):629-40. Review.

PMID:
17063617
[PubMed - indexed for MEDLINE]
14.

[Cell therapy and prostate cancer].

Eymard JC, Bernard J.

Bull Cancer. 2003 Aug-Sep;90(8-9):734-43. Review. French.

PMID:
14609763
[PubMed - indexed for MEDLINE]
15.

Vaccine therapy for prostate cancer.

Sonpavde G, Spencer DM, Slawin KM.

Urol Oncol. 2007 Nov-Dec;25(6):451-9. Review.

PMID:
18047951
[PubMed - indexed for MEDLINE]
16.

Immunotherapy for prostate cancer.

Rini BI, Small EJ.

Curr Oncol Rep. 2001 Sep;3(5):418-23. Review.

PMID:
11489243
[PubMed - indexed for MEDLINE]
17.

Prostate cancer vaccines: current status and future potential.

Doehn C, Böhmer T, Kausch I, Sommerauer M, Jocham D.

BioDrugs. 2008;22(2):71-84. Review.

PMID:
18345705
[PubMed - indexed for MEDLINE]
18.

The evolving role of immunotherapy in prostate cancer.

Gerritsen WR.

Ann Oncol. 2012 Sep;23 Suppl 8:viii22-7. doi: 10.1093/annonc/mds259. Review.

PMID:
22918924
[PubMed - indexed for MEDLINE]
Free Article
19.

Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge).

Harzstark AL, Small EJ.

Expert Opin Biol Ther. 2007 Aug;7(8):1275-80. Review.

PMID:
17696825
[PubMed - indexed for MEDLINE]
20.

Prostate cancer: advances in immunotherapy.

Hurwitz AA, Yanover P, Markowitz M, Allison JP, Kwon ED.

BioDrugs. 2003;17(2):131-8. Review.

PMID:
12641491
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk